東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/11 | 2,810 | 2,848 | 2,788 | 2,803 | -31 | -1.1% | 255,400 |
2023/09/08 | 2,822 | 2,918 | 2,791 | 2,834 | +51 | +1.8% | 415,100 |
2023/09/07 | 2,764 | 2,805 | 2,740 | 2,783 | -1 | ±0% | 186,100 |
2023/09/06 | 2,731 | 2,790 | 2,726 | 2,784 | +53 | +1.9% | 375,700 |
2023/09/05 | 2,710 | 2,742 | 2,681 | 2,731 | +13 | +0.5% | 358,700 |
2023/09/04 | 2,800 | 2,800 | 2,711 | 2,718 | -79 | -2.8% | 321,100 |
2023/09/01 | 2,791 | 2,818 | 2,760 | 2,797 | +17 | +0.6% | 277,800 |
2023/08/31 | 2,750 | 2,792 | 2,708 | 2,780 | +29 | +1.1% | 405,800 |
2023/08/30 | 2,783 | 2,828 | 2,689 | 2,751 | -16 | -0.6% | 851,100 |
2023/08/29 | 2,838 | 2,899 | 2,760 | 2,767 | +20 | +0.7% | 621,900 |
2023/08/28 | 2,756 | 2,800 | 2,745 | 2,747 | -35 | -1.3% | 399,700 |
2023/08/25 | 2,679 | 2,782 | 2,672 | 2,782 | +103 | +3.8% | 519,200 |
2023/08/24 | 2,687 | 2,697 | 2,635 | 2,679 | -41 | -1.5% | 447,700 |
2023/08/23 | 2,688 | 2,727 | 2,665 | 2,720 | +82 | +3.1% | 761,200 |
2023/08/22 | 2,568 | 2,695 | 2,561 | 2,638 | +162 | +6.5% | 985,100 |
2023/08/21 | 2,424 | 2,509 | 2,417 | 2,476 | +58 | +2.4% | 608,800 |
2023/08/18 | 2,300 | 2,449 | 2,298 | 2,418 | +127 | +5.5% | 919,100 |
2023/08/17 | 2,232 | 2,297 | 2,225 | 2,291 | +64 | +2.9% | 505,400 |
2023/08/16 | 2,117 | 2,227 | 2,108 | 2,227 | +95 | +4.5% | 484,600 |
2023/08/15 | 2,175 | 2,175 | 2,105 | 2,132 | -83 | -3.7% | 525,300 |
2023/08/14 | 2,174 | 2,222 | 2,131 | 2,215 | +326 | +17.3% | 992,500 |
2023/08/10 | 1,877 | 1,894 | 1,870 | 1,889 | +6 | +0.3% | 108,700 |
2023/08/09 | 1,884 | 1,885 | 1,857 | 1,883 | +10 | +0.5% | 84,800 |
2023/08/08 | 1,860 | 1,878 | 1,852 | 1,873 | +19 | +1% | 108,500 |
2023/08/07 | 1,836 | 1,865 | 1,832 | 1,854 | +19 | +1% | 96,500 |
2023/08/04 | 1,828 | 1,846 | 1,824 | 1,835 | +6 | +0.3% | 99,700 |
2023/08/03 | 1,847 | 1,847 | 1,820 | 1,829 | -21 | -1.1% | 133,900 |
2023/08/02 | 1,847 | 1,853 | 1,835 | 1,850 | +2 | +0.1% | 141,800 |
2023/08/01 | 1,808 | 1,848 | 1,805 | 1,848 | +49 | +2.7% | 213,300 |
2023/07/31 | 1,818 | 1,819 | 1,795 | 1,799 | -4 | -0.2% | 142,500 |
2023/07/28 | 1,785 | 1,806 | 1,776 | 1,803 | -3 | -0.2% | 122,600 |
2023/07/27 | 1,794 | 1,806 | 1,782 | 1,806 | +11 | +0.6% | 137,500 |
2023/07/26 | 1,794 | 1,796 | 1,782 | 1,795 | +1 | +0.1% | 120,100 |
2023/07/25 | 1,790 | 1,805 | 1,769 | 1,794 | +13 | +0.7% | 191,300 |
2023/07/24 | 1,774 | 1,782 | 1,743 | 1,781 | +32 | +1.8% | 189,400 |
2023/07/21 | 1,742 | 1,752 | 1,727 | 1,749 | +24 | +1.4% | 180,100 |
2023/07/20 | 1,756 | 1,756 | 1,720 | 1,725 | -31 | -1.8% | 188,300 |
2023/07/19 | 1,755 | 1,758 | 1,744 | 1,756 | +12 | +0.7% | 113,300 |
2023/07/18 | 1,730 | 1,744 | 1,728 | 1,744 | +14 | +0.8% | 117,500 |
2023/07/14 | 1,718 | 1,736 | 1,718 | 1,730 | +12 | +0.7% | 140,300 |
2023/07/13 | 1,714 | 1,732 | 1,711 | 1,718 | +3 | +0.2% | 111,400 |
2023/07/12 | 1,714 | 1,719 | 1,703 | 1,715 | +2 | +0.1% | 150,000 |
2023/07/11 | 1,717 | 1,726 | 1,711 | 1,713 | -14 | -0.8% | 195,900 |
2023/07/10 | 1,730 | 1,738 | 1,724 | 1,727 | -10 | -0.6% | 141,500 |
2023/07/07 | 1,747 | 1,747 | 1,726 | 1,737 | -22 | -1.3% | 154,900 |
2023/07/06 | 1,763 | 1,769 | 1,755 | 1,759 | -4 | -0.2% | 143,900 |
2023/07/05 | 1,754 | 1,766 | 1,748 | 1,763 | -2 | -0.1% | 152,300 |
2023/07/04 | 1,780 | 1,784 | 1,763 | 1,765 | -25 | -1.4% | 139,500 |
2023/07/03 | 1,778 | 1,802 | 1,778 | 1,790 | +19 | +1.1% | 96,800 |
2023/06/30 | 1,794 | 1,794 | 1,769 | 1,771 | -29 | -1.6% | 141,300 |
401~
450
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム